Description

4(3H)-Quinazolinone, 8-Methoxy-2-Methyl-3-[4-[3-(1-Piperidinyl)Propoxy]Phenyl]- is a high-purity, synthetically derived quinazolinone derivative of significant interest in advanced pharmaceutical research and development. This compound serves as a critical intermediate or active pharmaceutical ingredient (API) building block for the synthesis of novel therapeutic agents. It is primarily utilized by pharmaceutical R&D laboratories, contract research organizations (CROs), and fine chemical manufacturers targeting specific biological pathways.

Application

• Pharmaceutical Intermediate: Key building block in the synthesis of potential drug candidates targeting various disease states.
• Kinase Inhibitor Research: Used in the development and study of small molecule inhibitors for oncology and inflammatory disease research.
• Medicinal Chemistry: Serves as a core scaffold for structure-activity relationship (SAR) studies and lead optimization programs.
• Reference Standard: Employed as an analytical standard in quality control and method development for API manufacturing.
• Biochemical Research: Utilized in vitro and in vivo studies to investigate specific biological mechanisms and target engagement.
• Custom Synthesis: Starting material for the contract manufacturing of specialized, non-commercial compounds for client-specific research needs.

Basic Information

Product Name	4(3H)-Quinazolinone, 8-Methoxy-2-Methyl-3-[4-[3-(1-Piperidinyl)Propoxy]Phenyl]-
CAS No.	862308-94-9
Molecular Formula	C24H29N3O3
Molecular Weight	407.51 g/mol
Synonyms	8-Methoxy-2-methyl-3-[4-[3-(piperidin-1-yl)propoxy]phenyl]quinazolin-4(3H)-one; 3-[4-[3-(1-Piperidinyl)propoxy]phenyl]-8-methoxy-2-methyl-4(3H)-quinazolinone; UNII-9V6A2X6Q4J; 9V6A2X6Q4J; 862308-94-9; 8-Methoxy-2-methyl-3-{4-[3-(piperidin-1-yl)propoxy]phenyl}-3,4-dihydroquinazolin-4-one
EINECS	Contact for details

Quality Control

Our 4(3H)-Quinazolinone derivative is manufactured under strict quality management systems. Every batch undergoes comprehensive analytical testing, including HPLC for purity, NMR and MS for structural confirmation, and residual solvent analysis. We provide a detailed Certificate of Analysis (COA) with each shipment to ensure traceability and compliance with your research or cGMP-grade requirements. Specifications are designed to meet the stringent needs of pharmaceutical development.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (typically 15-25°C). This compound is hygroscopic (moisture-sensitive) and should be handled under dry conditions to maintain stability and purity. For long-term storage, consider desiccants or inert atmosphere.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (HPLC)	Conforms to reference standard
Identification (IR)	Conforms to structure
Purity (HPLC)	≥98.0%
Water Content (KF)	≤0.5%
Residue on Ignition	≤0.1%
Heavy Metals	≤20 ppm
Residual Solvents (GC)	Complies with ICH Q3C

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.